New research findings of the ENZAMET (ANZUP 1304) study, led by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP),...
Vous n'êtes pas connecté
Recent research from Saint Louis University School of Medicine shows significant improvements in the survival rates of men with metastatic prostate cancer over the past 20 years. This positive trend is linked to new hormonal treatments and chemotherapy. Dr. Martin Schoen, an assistant professor of medicine at Saint Louis University and a member of the […]
New research findings of the ENZAMET (ANZUP 1304) study, led by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP),...
A study based on clinical trial data found higher risks of stroke, heart attack, and hospital admission for heart failure in older cancer survivors....
A new GALAXY study reveals Signatera's cell-free DNA test predicts survival rates and chemotherapy benefits for colorectal cancer patients with high...
A new GALAXY study reveals Signatera's cell-free DNA test predicts survival rates and chemotherapy benefits for colorectal cancer patients with high...
A new survey conducted by the American Lung Association (ALA) highlights a troubling gap in awareness about early detection of lung cancer through...
A new survey conducted by the American Lung Association (ALA) highlights a troubling gap in awareness about early detection of lung cancer through...
A multi-institutional clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators showed that a newer technique for collecting...
BAYRY moves ahead with the submission of an application seeking approval of darolutamide in combination with androgen deprivation therapy in patients...
Collaboration to include the clinical development, regulatory filing, and commercialization in Japan of 177Lu-PSMA-I&T and 64Cu-PSMA-I&T Builds on...
Despite advancements in early detection and innovative treatments, Black women in the United States face higher mortality rates from breast cancer...